Harris, Patrick N.A., Peleg, Anton Y., Iredell, Jon, Ingram, Paul R., Miyakis, Spiros, Stewardson, Andrew J., Rogers, Benjamin A., McBryde, Emma S., Roberts, Jason A., Lipman, Jeff, Athan, Eugene, Paul, Sanjoy K., Baker, Peter, Harris-Brown, Tiffany, and Paterson, David L. (2015) Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial. Trials, 16 (24). pp. 1-8.

Cerqueira, Gustavo M., Kostoulias, Xenia, Khoo, Chen, Aibinu, Ibukun, Qu, Yue, Traven, Ana, and Peleg, Anton Y. (2014) A global virulence regulator in Acinetobacter baumannii and its control of the phenylacetic acid catabolic pathway. Journal of Infectious Diseases, 210 (1). pp. 46-55.

Abbott, Iain, Cerqueira, Gustavo M., Bhuiyan, Saruar, and Peleg, Anton Y. (2013) Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies. Expert Review of Anti-infective Therapy, 11 (4). pp. 395-409.

Peleg, Anton Y., de Breij, Anna, Adams, Mark D., Cerqueira, Gustavo M., Mocali, Stefano, Galardini, Marco, Nibbering, Peter H., Earl, Ashlee M., Ward, Doyle V., Paterson, David L., Seifert, Harald, and Dijkshoorn, Lenie (2012) The success of acinetobacter species; genetic, metabolic and virulence attributes. PLoS ONE, 7 (10). e46984. pp. 1-11.

Cerqueira, Gustavo M., and Peleg, Anton Y. (2011) Insights into Acinetobacter baumannii pathogenicity. IUBMB Life, 63 (12). pp. 1055-1060.